JMethod of Grading. The system of histological grading introduced into this country by Patey and Scarff (1928) will be used. This is based upon the principles formulated by all under the age of 30. Fifty-nine patients were treated by a radical mastectomy with a five-and ten-year survival rate of 41 per cent and 37 per cent respectively. These results are relatively good. In fact, they are even superior to those obtained in a general series studied by the same author-34 per cent five-year and 22 per cent ten-year survival rates (Eggers, de Cholnoky and Jessup, 1941) .
Hawkins (1944) , in an investigation of some 2,600 cases showed a comparable five-year survival rate in three age groups, namely, 49 and less, 50 to 59 and over 60. The author concluded that these findings do not support the fiequent contention that the younger cancer patients have a worse outlook than the older groups.
Age was not found to be an important factor in prognosis by Wyard (1925) , Greenwood (1926) , Evans and Leucutia (1930) , Lewis and Reinhoff (1932) , Matthews (1933) , Scarf and Handley (1938) , Macdonald (1942) , Hoopes and McGraw (1942) , Haagensen and Stout (1943) , Truscott (1947) and Harnett (1948) . Lane-Claypon (1924) in her survey for the Ministry of Health demonstrated a similar survival rate among some 500 cases classified according to decade. In a further paper (Lane-Claypon, 1928 ) some 1,800 cases were divided into three age groups-less than 40, 40 to 50, and 60 and over. From a study of the survivals for each group, the author concluded that "the statement commonly made that the prognosis is worse in younger persons is erroneous."
More recently, Harrington (1946) in a large series of cases from the Mayo Clinic found no relationship between age and the number of survivals at five years. In addition, the effect of age on the incidence of axillary metastases was investigated. The proportion of cases with this complication were found to be comparable in the majority of groups. Similarly, 59 per cent of the young patients reported by de Cholnoky (1943) had axillary involvement compared with 64 per cent in the same author's general series (Eggers, de Cholnoky and Jessup, 1941) .
Can a relationship between age and prognosis be shown in the present series ? The age was available in 461 cases. The youngest patient was 22 and the oldest 80. Table I displays the five-year survivals in the various decades. The results of a broader grouping are also presented (Table HI) .
If we examine Table I between age and outcome, and there is no support for the view that the tumours of younger women, apart from those associated with pregnancy and lactation, kill more rapidly. Of patients aged 39 or less, 42 per cent were alive at five years compared with 38 per cent in the seventh decade. When the cases are separated out, as in Table II , it is clear again that the younger patients fare no worse than do the older ones, in fact, if anything, they do rather better. This has also been the finding of Lane-Claypon (1928) and Hawkins (1944) . Geschickter (1945) believes that certain unfavourable features exist for younger women with breast cancer, but that these are compensated for by the fact that such patients, as shown by Kaae (1948) , tend to seek medical advice sooner than do older groups. Where the prognosis has been found to be comparable for various ages it may be argued that this factor has come into operation. Hence. it may not be adequate to consider the prognostic significance of age purely from the results of treatment.
Many authors who claim a parallel to exist between age and outcome maintain that the breast cancers of younger women tend to be more anaplastic and grow more rapidly than do those in older women. If this is true one would expect to find a greater proportion of growths of high grade malignancy among the younger cases, and a preponderance of low grade tumours in the older groups. Such a discovery would be conclusive evidence for the view that the younger the patient the graver the outlook. Now, several workers have shown that the degree of malignancy in mammary carcinoma can be ascertained by examining a section of the tumour. Attempts, however, to correlate the histologyv of cancer with age appear to have been rarely performed. Up to the present time only two investigations of this type have been found in the literature (Taylor, 1936 Lees and Park, 1949) . A study on these lines will now be made. (1948) . In spite of the improvement, compared with earlier investigations, these figures are still far from satisfactory. On the other hand, reports from elsewhere are much more gloomy. Lewis and Reinhoff (1932) Putzki and Scully (1946) in 88 per cent. The " duration of symptoms," therefore, in the vast majority of cases refers to the length of time a tumour has been present in the breast-from the time the patient found it to the time she attended the hospital clinic.
The responsibility for prolonged delay before the institution of treatment may be entirely that of the patient, but not always. Medical practitioners are occasionallv guilty of wasting time, especially with regard to younger women when cancer is not suspected. Kaae (1948) found that in his series three-quarters of the cases were subjected to adequate therapy within one month and 90 per cent within six months of the first medical examination. Lane-Claypon (1926) reported a mean interval of five to six months between the consultation and operation among 670 cases.
Whenever the management of malignant disease is discussed the importance of early diagnosis and early treatment are emphasized. In the case of mammarv carcinoma, has the duration of symptoms anv bearing on prognosis ? The general teaching has certainly always been that the greater the delay in seeking treatment in this disease the worse the outlook. The impression is also frequently given that if a patient receives earlv therapy the prognosis is necessarily good. These views meet with almost universal acceptance, and only very rarely have thev been questioned. Are they in point of fact well-founded ? For if they are, we should direct more attention to reducing the tragically large numbers of women who, through fear or ignorance, fail to seek medical care until many months have elapsed following the discovery of a lump in the breast. If we can accomplish this, will the number of survivals at five and ten years after operation increase ? Mlanv authorities believe thev will. Let us now consider the opinions which have been expressed regarding the duration of symptoms and prognosis. Luff (1932) , in an investigation of over 1,500 cases for the British MLNedical Association, found that the longer the delay between the first symptom and operation the more gloomy the outlook, as shoWn by the survival, recurrence and mortality rates (Table IV) . A study of this table reveals that with a delay of twelve months the survival rate is halved and the recurrence rate more than doubled. Cade (1950) refers to Luff's work and states that" the mortality of cancer of the breast in England and Wales could be reduced from 7,000 yearly to 1,000, if all cases were adequately treated in the first month of the appearance of the disease." TABLE IV.-Prognosis and Duration of Symptoms (Luff, 1932 From the preceding data it would appear that duration of symptoms has a direct bearing on prognosis-the longer they have been present the worse the outlook. The significance of the increase in the survival rates after a delay of one or more years, as found by Mfacdonald (1942) and also by Eggers. de Cholnokv and Jessup (1941) , will be discussed later.
What can be revealed in the present series of cases as to the relationship between delay in seeking treatment and prognosis ? Information regarding this point was available in 406 instances. The five-vear survivals were determined according to the duration of symptoms, and these are displayed in Table V Hoopes and McGraw (1942) and Macdonald (1942) . Our results also appear to conflict with generally accepted views, but thev are not unique. Lewis and Rienhoff (1932) This problem must be now examined more closely. So far, we have studied the cases as a whole. No attempt has been made to classify them, and the importance of this procedure has been stressed elsewhere (Bloom, 1950) . What types of cases are present in the various groups shown in Table V ? It is possible that these groups are not comparable. For example, there mav be a preponderance of highly malignant tumours among the women attending hospital within the six-week period, whilst there exists but a small proportion of similar growths among those delaying for one year or longer. Such a distribution may compensate for the difference in time, and thus account for the practically identical endresults.
Cases of breast cancer may be classified by clinical stage or histological grade. Let us first of all consider the scatter of the patients according to stage and duration of symptoms. For this purpose the Manchester svstem was employed, a summary of which may be found in our previous report (Bloom, 1950 state of affairs is seen for those in Stage 2. On the other hand, the advanced cases (Stages 3 and 4) increase in number with prolonged delay. In other words, as more and more time elapses from the onset of the disease, as determined bv the patient, so the early and moderately advanced tumours fall in number whilst the proportion of more extensive growths becomes greater. These results deserve no special comment. They are what one expects and support the conclusions of Kaae (1948) that " with increasing duration of symptoms the number of Stage 1 cases becomes steadily less and there is a gradual increase in the number of inoperables. . . .' On the other hand, these findings make it even more difficult to understand those shown in Table V . For instance, the percentage of Stage 1 and Stage 3 cases among the patients presenting within six weeks of the first symptom is 39 per cent and 19 per cent respectively (Table VI) . After a delay of one year or more the proportion of early cases falls to 25 per cent, whilst the advanced cases increase to 44 per cent. And yet, in spite of this, the five-year survival rate is practically the same-O0 per cent for those having a delay of six weeks or less compared with 52 per cent for those waiting one year or longer (Table V) In view of these findings let us once again consider the relationship between duration of symptoms and prognosis, but this time according to the grade of malignancy (Table X) . It is evident that outcome is now shown, in certain cases. We are compelled to adopt the view that outcome in mammary-carcinoma is determined largely by the histological type of growth. rather than by prompt treatment as soon as the lesion is discovered. Macdonald (1942) expresses a similar opinion when he states that ' natural selection ' is more important in prognosis than early therapy. Kunath (1940) considers that " the rate of growth"' is the major factor influencing end-results rather than the length of time the tumour has been present. In fact, Nathanson and WVelch (1936) (1941) . M3acdonald (1942) and Harnett (1948) . In the present series no such increase was observed when the patients were taken as a whole (Table V) Doubt has been expressed as to the value of surgical treatment, purely on account of a long history (Davis, 1938) . From the evidence presented in Table X it would appear that such a view is not onlv fallacious, but also extremely dangerous; of the patients with symptoms lasting one year or more, over three-quarters of those belonging to Grade I and fully a half of those of Grade II were alive five years after operation.
In conclusion: we believe that campaigns aimed at shortening the delay before seeking medical advice should not only be continued, but also intensified, if only for the sake of those patients having tumours oflow histological malignancy.
It is most important, however, to realize that such measures alone must not be relied upon to increase the number of five-and ten-year survivors. We have revealed that the prognosis of certain cases does not appear to be materiallv influenced by the institution of early therapy. In fact, it is misleading to state, as so often is done, that the outlook is usually good for patients who present promptly after the onset of svmptoms.
SITE OF TTMOUR AND PROGNOSIS.
Before investigating the relationship between site of growth and prognosis in breast carcinoma, let us first examine the frequency with which various parts of the gland are involved by this disease.
The incidence of cancer in either breast appears to be about equal. A number of reports, however, suggest a slight preponderance, to the extent of 4 or 5 per cent, for the left side over the right (Luff, 1932; W,evill, 1932; Busk and Clemmesen, 1947 ; Harnett, 1948) .
The region of the breast affected was studied in the present series, the usual subdivisions into quadrants, axillary tail and centre being made. Adequate information regarding the site of the growth was available in 441 cases. In 52 of these the tumour was described as being situated in a hemisphere, or in the midline of two adjacent quadrants. Four patients were said to have more than one lump in different quadrants of a single breast. It was thought best to exclude these 56 cases from the series, leaving 385 for consideration. The distribution of the tumours, which is drawn out in Table XI , reveals a well-marked preponderance of the upper outer quadrant of the breast as the site for mammary cancer. The frequencies given here for the different regions agree verv closely with those of previous workers at the MIiddlesex Hospital, also shown in Table XI . The somewhat higher incidence of central" growths found by Campiche and Lazarus-Barlow (1905), Beckton (1909) and Truscott (1947) is probably accounted for by the inclusion in this group of large growths involving three or more quadrants. WVe have preferred to classify these separately under the heading of "diffuse " or " whole breast." The results obtained at this hospital differ in no way from those reported elsewhere (Lane-Claypon, 1924; Luff, 1932; Wevill, 1932; Geschickter, 1945; Harnett, 1948) . Having noted the frequency with which the various parts of the breast are the seat of cancer, we will now consider whether these sites have any prognostic significance. Many opinions have been expressed, but there is no general agreement on this point. Handley (1922 Handley ( , 1927 was the first to stress the importance of the internal mammary chain of lymph glands as an avenue of extension for malignant cells to the thorax and abdomen. Because of the proximity to these surgically inaccessible nodes, carcinomas arising in the inner half of the breast are alleged by some authors, such as Bartlett (1933) and Hawkins (1944) , to carry a more gloomy prognosis than those situated in the outer hemisphere.
It has also been stated that cancer in the upper outer-or lower inner quadrants is more likelv to prove fatal at an early date. the former being in close relation to the axillary lymph glands and the latter to the abdominal viscera. A similar opinion has been expressed for tumours in the region of the nipple, owing to the presence of the sub-areolar plexus of Sappey which drains to the axilla. LaneClaypon (1924) found support for these views in a group of some 300 cases. This same author, however, in a later, more extensive study (Lane-Claypon, 1928) was unable to confirm her previous results, and finallv decided that there is no evidence that the prognosis varies according to the site.7' More recently, Truscott (1947) and also Harnett (1948) have reached a similar conclusion.
The relationship between site and survival rate was examined in the present series, the results being shown in (Table XIII) . The survival rate is again seen to be less for the inner region, but the difference is very small and therefore of doubtful significance. Consequently, we have not been able, so far, to prove that tumours situated in the sternal half of the breast carry a more gloomy outlook than those in the axillary half. In fact, a previous writer from this Hospital (Truscott, 1947) found that patients with growths in the lower inner quadrant had the lowest mortality.
When we have been previously faced with conflicting opinions on various aspects of breast cancer, considerable assistance has been obtained by studying the morbid histology of our cases. Let us, therefore, apply the principle of grading to the present problem.
First of all, what types of cases are present in the various groups we have considered in Table XII ? The distribution according to the grade of malignancy is shown for each site in Table XIV . It is evident that the poor prognosis for the small number of patients with axillary tail growths could be entirely accounted for by the preponderance of highly malignant tumours in this group, there being 71 per cent Grade III but no Grade I cases. A study of those patients classified as having " diffuse " cancers shows a similar state of affairs. In this instance 61 per cent of the patients had Grade III tumours, whilst only 11 per cent were Grade I. The widespread nature of these growths and the poor prognosis would, therefore, appear to depend upon the high incidence of extremely malignant tumours.
Further examination of Table XIV reveals that, in contrast to the " axillary" and " diffuse " tumours, the proportion of the three types of cancer in the central and various quadrant positions of the breast is very similar. Hence, in these cases we cannot evoke the distribution of the tumours to account for the slight differences in the five-year survival rates.
With regard to the cases separated out according to inner and outer hemisphere involvement (Table XIII) , the scatter of the cases in each group is again seen to be similar (Table XV) . We conclude from the present investigation that, generally speaking, site of tumour in breast cancer exerts no striking effect on prognosis, apart from those patients in whom the growth involves a large part of the gland, and this is largely determined by the histological type of neoplasm (i.e. Grade III). On the other hand, the outlook for the women with centrally placed growths may be slightly less favourable than for those with quadrant tumours, presumably because of their close proximity to the sub-areola lymphatic plexus of Sappey. Cases of low grade malignancy may be influenced to a minor degree by the site of the growth, depending upon whether the sternal or axillary half of the breast is affected (Table XVI) . The reason for this may be as follows. Site is of no consequence for Grade III tumours owing to their tendency to metastasize early no matter where they are situated, rapid, wide-spread secondary deposits appear to be the rule. In contrast to this, Grade I tumours disseminate much less readily. Hence site becomes important, the nearer these growths are to inac-*361 cessible channels of spread (e.g. internal mammarv chain), the greater the likelihood of such secondary involvement having taken place before the primary is removed.
SIZE OF TUMOUR A-D PROGNOSIS.
Can the size of the tumour prove of any value in assessing outcome in mammary carcinoma ? Geschickter (1945) points out that this feature is seldom discussed, although it is usually agreed that cancer occupying the entire gland is most frequently hopeless. In the present series there were 18 cases in which the growth was described as being "' diffuse ' or occupying the " whole breast," and of these only 17 per cent survived five years. Such cases are now rarely seen. What of the prognostic significance of smaller, less advanced growths ? Here again. as with so many other aspects of breast cancer, opinions do not agree. Kunath (1940) failed to find a correlation between size of tumour and prognosis. A similar result was obtained by Hoopes and McGraw (1942) . On the other hand, Eggers, de Cholnokv and Jessup (1941) showed a five-year survival rate of 73 per cent for patients with neoplasms of 2 cm. or less. With an increase of size (3 to 6 cm.) the survivals dropped to 24 per cent. reaching 16 per cent for the largest growths (7 cm. or more).
In the present study information regarding the size of the tumour was available in 350 cases. These were separated out into three groups and the survival rates determined (Table XVII ). An examination of this table reveals that the prognosis deteriorates as the tumour increases in size. So far, we have considered the cases as a whole, no allowance having been made for the different types of growth. The importance of taking this into account is obvious. For example, it would be fallacious to compare a small, highly malignant growth with one of large dimensions, but of low grade malignancy. Geschickter (1945) also refers to this point-" the size of the tumour is a reliable index of prognosis only if the pathological type is taken into consideration." It therefore follows that the better outlook for smaller turmours may result from a greater proportion of cases of low grade malignancy existing in this group. The converse would apply to the larger growths, here there being a preponderance of highly malignant examples. This, indeed, was found to be the case in the present investigation (Table XVIII) . Of the tumours with a diameter of 1 inch or less. 37 per cent are classified as Grade I and 23 per cent as Grade III. On the other hand, in the case of growths of more than 2 inches diameter only 8 per cent belong to Grade I whilst 54 per cent are Grade III. When the diameter lies between 1 and 2 inches the incidence of these tumours is practicallv the same.
The distribution of cases as shown in Table XVIII once again emphasizes the importance of the histological type of growth in cancer of the breast. A further study must therefore be made in which attention is given to size and prognosis Total . 37 100 according to grade of malignancy. Owing to the small number of patients with tumours over 2 inches in diameter, only two groups of cases will be considered instead of the original three-those with growths below and above 1 inch diameter. (Grade II) , the survival rate being practically halved in the presence of the larger neoplasms. In other words, the metastasizing power for Grade I and also Grade m cancers is independent of size. For growths classified as Grade H this power bears a direct relationship to the diameter, the larger the tumour the greater the likelihood of spread having taken place.
We consider that the conflicting opinions expressed regarding the relationship between size of tumour and prognosis in mammary carcinoma result from the study of histologically incomparable groups of cases. It is now generally believed that breast cancer, when associated with pregnancy or lactation, is particularly virulant and bears a bad prognosis. This complication was not reported as being present in any of the cases in the present investigation. For the sake of completeness, however, brief attention will be given to this feature by referring to the work of other authors.
The gloomv outlook for these patients is well supported by Lee (1931) who, in a small group of 25 cases, finds only 8 per cent alive and well three years after operation. A larger investigation was carried out by Harrington (1937 (Cade, 1950) .
WA-hat is required now is a histological study to determine the incidence of the different types of breast cancer occurring in pregnancy. If the tendency is towards a high degree of malignancy, and this would appear to be the case from the clinical data, then a preponderance of Grade III cases is to be expected. Unfortunately, this view cannot be confirmed at the present time owing to the lack of material. It is intended, however, to undertake such a studv at a later date. Meanwhile, we may refer again to Harrington (1 937). This author graded the tunours of 80 of his cases according to the method of Broders (which is based on four grades), and found that practically all were of a high degree of malignancy; in point of fact, there was not a single instance of a Grade 1 case and only 6 per cent belonged to Grade 2, whereas 25 per cent were of Grade 3 and 69 per cent of A number of clinical factors which have been claimed to influence prognosis in carcinoma of the breast have been examined. We believe that much of the controversy which centres around these problems has developed as the result of studying groups of cases which are not comparable from the histological point of view.
The importance of the microscopic appearance of the tumour in classifying and assessing the prognosis of patients with breast cancer has been stressed elsewhere (Bloom, 1950) . This feature has been taken into account in the present investigation, and from the results we conclude that, in spite of widely held views to the contrary, the age of the patient, the duration of symptoms and the site of the primary growth exert little or no influence on the ultimate outcome. A prognostic factor of far greater importance would appear to be the type of tumour as determined by a histological grading system-a factor which, unfortunately, is almost entirely neglected at the present time.
From this and our previous work the assistance that can be given by the pathologist to those dealing with the clinical aspects of breast cancer is obvious. We consider that many of the problems which have arisen concerning the results of treatment of this disease depend upon the inaccurate grouping of cases. It is hoped that the wider use of morbid histology will help to reduce this source of error to a minimum, and so enable us to assess the true merits of the various lines of therapy; this is our ultimate aim. SUMMARY. 1. The present work is a continuation of the investigation into the problems of prognosis in mammary carcinoma reported recently in this Journal (Bloom, 1950) .
2. The relationship between the age of the patient and prognosis was studied.
No significant differences in outcome were revealed in the various age groups, the younger women faring no worse than the older ones. These findings were confirmed by the fact that the incidence of tumours of low and also of high malignancy in the various decades was practically the same. 3. It is useless to try to assess the effect of the delay in seeking treatment without reference to the histological type of growth involved. For example, delay is oflittle importance for patients with highly malignant (Grade m) tumours; it does not seem to matter whether such cases attend for treatment early (less than 6 weeks) or late (6 to 12 months), the prognosis is equally bad. On the other hand, the time factor appears to influence the outlook of women with growths whose behaviour is essentially more benign (Grade I). In this type of case a loss of more than 6 months means a substantial fall in the survival rate.
4. The site of the tumour in the breast was, generally speaking, found to exert no striking effect on prognosis. However, it is possible that the outlook for patients with growths of low grade malignancy may be influenced slightlv by this feature, depending on whether the medial or lateral hemispheres are involved.
5. WNThen the patients were considered as a whole the size of the primary growth was found to influence prognosis, the larger the tumour the lower the survival rate. It is in the intermediate grade of tumours that these differences are especially found, and it is cases of this grade that are largely responsible for the general result. Size was evidently of no prognostic importance for women with tumours of a low and also a high grade of malignancy. It did not appear to matter whether the growths were small or large, the outlook was uniformlv good in the former and bad in the latter group. In contrast to this, the prognosis for neoplasms of an intermediate degree of malignancy showed marked deterioration with increase of size.
6. Brief reference has been made to the progress of cases of breast cancer when associated with pregnancy or lactation.
Note by T.E. Cowan, Esq., F.C.I.S., F.R.S.S.: The inferences drawn from the tables shown are statistically sound.
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